Lujin Li
Impact in
- Microbiology top 10%
- Reproductive tract infections research
-
- Menopause: Health Impacts and Treatments
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Oncology 8
- Co-authors
- Qingshan Zheng (53 shared papers)Ling Xu (11 shared papers)Yinghua Lv (14 shared papers)Jihan Huang (12 shared papers)Yingchun He (11 shared papers)Yucheng Sheng (4 shared papers)Hongxia Liu (10 shared papers)Huafang Li (4 shared papers)
- Journals
- European Journal of Clinical Pharmacology (6 papers)Frontiers in Pharmacology (3 papers)Acta Pharmacologica Sinica (3 papers)Cochrane Database of Systematic Reviews (2 papers)The Journal of Clinical Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Lujin Li
62 papers receiving 560 citations
Peers
Comparison fields: 5 of 91
- Microbiology 38
- Endocrinology, Diabetes and Metabolism 65
- Pathology and Forensic Medicine 63
- Biological Psychiatry 8
- Pharmacology 49
Countries citing papers authored by Lujin Li
This map shows the geographic impact of Lujin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lujin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lujin Li more than expected).
Fields of papers citing papers by Lujin Li
This network shows the impact of papers produced by Lujin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lujin Li. The network helps show where Lujin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lujin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 53 | |
| 2 | 2019 | 46 | |
| 3 | 2013 | 39 | |
| 4 | 2019 | 34 | |
| 5 | 2016 | 27 | |
| 6 | 2015 | 22 | |
| 7 | 2010 | 21 | |
| 8 | 2017 | 19 | |
| 9 | 2022 | 17 | |
| 10 | 2019 | 14 | |
| 11 | 2019 | 14 | |
| 12 | 2020 | 13 | |
| 13 | 2019 | 12 | |
| 14 | 2018 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2024 | 10 | |
| 18 | 2021 | 9 | |
| 19 | 2019 | 9 | |
| 20 | 2020 | 9 |
About Lujin Li
Lujin Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Physiology and Infectious Diseases, having authored 67 papers that have together received 575 indexed citations. Recurring topics across this work include Menopause: Health Impacts and Treatments (3 papers), Treatment of Major Depression (3 papers), Statistical Methods in Clinical Trials (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Pneumonia and Respiratory Infections (2 papers) and Pediatric health and respiratory diseases (2 papers). The work is most often cited by research in Microbiology (38 citations), Endocrinology, Diabetes and Metabolism (65 citations), Pathology and Forensic Medicine (63 citations), Biological Psychiatry (8 citations) and Pharmacology (49 citations). Lujin Li has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Qingshan Zheng, Ling Xu, Yinghua Lv, Jihan Huang, Yingchun He, Yucheng Sheng, Hongxia Liu, Huafang Li, F Yin and Ling Xu. Their work appears in journals such as European Journal of Clinical Pharmacology, Frontiers in Pharmacology, Acta Pharmacologica Sinica, Cochrane Database of Systematic Reviews and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.